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Pre-and peri-natal events play a fundamental role in health, the development of diseases and 
ageing (Developmental Origins of Health and Disease: DOHaD). Research on the 
determinants of active and healthy ageing (AHA) is a priority: (i) to inform strategies for 
reducing societal and individual costs of an ageing population and (ii) to develop effective 
novel prevention strategies.
The European Union (EU) leads a global effort to understand the early determinants of 
ageing. The Polish Presidency of the EU Council (2011) targeted chronic respiratory 
diseases in children to promote AHA (1). The developmental determinants of chronic 
diseases in ageing were reinforced during the Cyprus Presidency of the EU Council (2012). 
Several projects of the EU Sixth and Seventh Framework Programme for Research and 
Technological Development (FP6 and FP7) were funded to understand the mechanisms of 
pre-natal and early life events on the development of chronic diseases. One of the action 
plans of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) 
is devoted to integrated care for chronic diseases, and chronic respiratory diseases have been 
selected as the model for chronic diseases.
As part of this research initiative, a meeting in Montpellier, December 2 and 3, 2013 
attempted to better understand the early life events that may impact ageing in health and 
disease, with a particular focus on respiratory diseases. The results of the FP6 and FP7 
projects on population-based cohorts in adults and old age were reviewed to propose novel 
research, policies and value creation. The full report is in the online supplement and on the 
MACVIA-LR website (macvia.cr-languedocroussillon.fr).
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Importance of life course models to understand healthy ageing and disease
Biological ageing is the progressive deterioration of function that occurs in the post-maturity 
phase, and can be assessed at the individual, physiological systems and cellular levels (2). 
Cross cohort comparisons of British birth cohorts show that social and biological factors 
from early life onwards can affect ageing, in particular respiratory function and disease.
In order to detect health-promoting factors, the early life events of diseases such as COPD 
need to be understood (European COST action BM1201: Developmental Origins of Chronic 
Respiratory Disease (3)). Susceptibility to COPD is associated with markers of foetal growth 
and early childhood disadvantage. Lung function at birth is determined by in utero 
processes.
Future research needs to develop a life course model of ageing that integrates the 
rather separate research on specific diseases or clinical conditions, functional 
ageing and wellbeing and should include socio-economic characteristics.
Birth cohorts focusing on chronic respiratory diseases in the general 
population
Asthma and allergic diseases begin early in life. Birth cohort studies are relevant to 
investigate environmental and lifestyle determinants of asthma and IgE-associated diseases 
or the absence of such diseases. Over 30 community-based birth cohorts focusing on asthma 
and allergies have started in Europe and many have been pooled (4). The Network of 
Excellence GA2LEN (FP6, contract N° FOOD-CT-2004-506378) has initiated birth cohort 
harmonisation. Two Concerted Actions, CHICOS (FP7 No. 241604) and ENRIECO (FP7 
grant agreement N° 226285), have built a network of more than 70 birth cohorts across 
Europe. MeDALL (Mechanisms of the Development of ALLergy, FP7 No. 261357) 
attempts to generate novel knowledge on the mechanisms of allergy onset and propose early 
diagnosis, prevention and targets for therapy based on a new standardised follow up of birth 
cohorts in Europe.
Numerous cohort studies have shown that early decrements in spirometry persist into late 
middle age, underscoring the crucial importance of early life influences. Optimal lung 
development depends on normal airway function at birth as well as normal growth during 
childhood up to the plateau of spirometric function around 25 years of age. After this, lung 
function declines as a normal event.
The geographical and temporal diversities of birth cohorts in MeDALL provide an 
excellent opportunity to study the effects of living conditions in different places, 
since these are likely to be major determinants in the causation of the wave of 
chronic diseases currently observed.
An NIAID, NHLBI, MeDALL joint workshop (September 2012) (5) has identified over 60 
birth cohorts focusing on asthma and allergy worldwide in order to (i) document the 
knowledge obtained, (ii) identify the knowledge gaps and inconsistencies and (iii) develop 
strategies for moving forward. Following the workshop in 2012, an online database 
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containing information about existing cohorts was created to facilitate collaboration 
(AsthmaBirthCohorts.niaid.nih.gov).
Some population-based birth cohorts (PIAMA, BAMSE, ECA, MAS) have information on 
chronic diseases and their risk factors and can assess chronic diseases and AHA across the 
life cycle.
Nutrition, obesity and diabetes across the life course
Chronic diseases often start early in life and their processes expand over the life course. 
DORIAN (Developmental ORigins of healthy and unhealthy AgeiNg: The Role of Maternal 
Obesity, FP7) aims at linking studies of early developmental processes with those of ageing 
from a life course perspective.
A better knowledge on the developmental origin of obesity and type-2 diabetes 
may lead to preventive measures in order to reduce the global epidemic of these 
two diseases.
Nutrition is vital for health and disease prevention. The Supplementation with Antioxidant 
Vitamins and Minerals (SU.VI.MAX) Study was a controlled trial (12,741 persons) 
followed-up for 8 years (1994-2002) to test the efficacy of dietary manipulations in lowering 
the incidence of chronic diseases and cancer. No supplementation was administered to 
participants in SU.VI.MAX 2. Food intake and nutritional factors in infancy and childhood 
have also been studied in several of the ongoing European birth cohorts, which allows for 
unique longitudinal association analyses on various chronic diseases.
Nutrition is vital to understand the development of chronic diseases and the 
promotion of healthy ageing.
Adult cohorts in chronic diseases
The French prospective cohort (E3N), the EPIC-France cohort, is composed of women who 
were under a health insurance plan, the Mutuelle Générale de l’Education Nationale, for 
schoolteachers and co-workers. In 1990, about 100,000 women (40-65 years) were recruited. 
Epidemiological research in nutrition, hormones and chronic diseases (asthma, diabetes or 
osteoporosis) studied the risk factors for developing these diseases.
Two large European epidemiological cohorts, recruited in the early 1990s and followed up 
for 20 years, have been carried out in respiratory health: (i) the European Community 
Respiratory Health Survey (ECRHS, http://www.ecrhs.org/), including 18,668 individuals 
aged 20-44 years at baseline; (ii) the Epidemiological study of the Genetics and 
Environment of Asthma, bronchial hyperresponsiveness and atopy (EGEA, http://
egeanet.vjf.inserm.fr), a French case–control and family study of adults and children at 
baseline, including 2,120 individuals aged 7-70 years at baseline. Combined analyses 
between these cohorts have been performed.
COPACETIC, a cohort of the lung cancer screening trial with over 2,200 individuals with 
lung function and CT scans, identified genes associated with lung function decline in 
interaction with smoking, CT scan based emphysema and coronary calcifications.
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LifeLines (The Netherlands) is a three-generation cohort of 165,000 individuals followed 
annually by questionnaire and, each 5 years, by extensive functional screening of the 5 
prime research areas: (1) metabolic/hormonal, (2) heart/vessel/kidney, (3) lung/respiratory/
allergy, (4) psychiatric and (5) musculoskeletal.
Adult cohorts include participants that have been followed up for a long period of 
time, and may be used to link the development of factor profiles of chronic diseases 
from early life.
Old age cohorts
Neuropsychiatric disorders of old-age (eg depression, Alzheimer’s disease) may be 
determined by earlier risk exposure. The DEVELAGE consortium (FP7) aims to 
characterise shared molecular pathways between the early developmental processes in the 
brain and brain ageing.
This example underlines the limits of old age cohorts in the study of chronic 
neuropsychiatric disorder in the elderly.
Integrated research on DEvelopmental determinants of Ageing and Longevity (IDEAL; 
www.ideal-ageing.eu, FP7) examines the role of epigenetic regulation and transmission to 
next generations. A unique human cohort and animal studies are studied to discover novel 
longevity pathways and the links between development and ageing.
The Three-City Study (3C Study) is a population-based longitudinal study of the relation 
between vascular diseases and dementia in persons aged 65 years and older. 9,294 
participants of both sexes were recruited from three French cities.
CONSTANCES, a large general-purpose epidemiologic population-based cohort, aims to 
provide public health information. The cohort is a representative sample of 200,000 French 
adults, aged 18-69 years at inception.
Cohorts in middle and old age adults can be intertwined with earlier cohorts to 
understand the mechanisms of AHA and diseases in ageing.
Recommendations for future research are reported in the online supplement and the 
MACVIA-LR website on (i) integration of omics in epidemiologic studies across the life 
cycle (ii), performance of longitudinal studies assessing chronic diseases and (iii) value of 
European birth cohorts to study chronic diseases and AHA. Cohorts with an initial focus on 
chronic respiratory diseases could be expanded to understand the trajectories of chronic 
diseases and AHA.
Cohorts across the life cycle are essential to understand AHA. Life-long birth 
cohorts give an overview of the problem and are complemented by cohorts carried 
out at different ages. Birth cohorts initially focusing on chronic respiratory diseases 
offer a highly valuable additive information to understand chronic diseases and 
AHA.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbreviations
AHA Active and healthy ageing
BAMSE Barn Allergi Milj. Stockholm Epidemiologi Projektet
CHICOS Developing a Child Cohort Research Strategy for Europe
COPACETIC COPD Pathology: Adressing Critical gaps, Early Treatment & diagnosis 
and Innovative Concepts
COPD Chronic obstructive pulmonary disease
COST European Cooperation in Science and Technology
DARC Study: Danish Allergy Research Centre study
E3N Étude Épidémiologique auprès de femmes de la MGEN (Mutuelle 
Générale de l’Éducation Nationale)
ECA Environment and Childhood Asthma
EIP on AHA European Innovation Partnership on Active and Healthy Ageing
ENRIECO Environmental Health Risks in European Birth Cohorts
EPIC European Prospective Investigation into Cancer and Nutrition
EU European Union
FP Framework Program for Research and Technological Development
GA2LEN Global Allergy and Asthma European Network
MACVIA-LR Contre les MAladies Chroniques pour un VIeillissement Actif en 
Languedoc Roussillon (EIP on AHA Reference site)
MAS Multi-centre Allergy Study
MeDALL Mechanisms of the Development of ALLergy
NHLBI National Heart Lung and Blood Institute
NIAID National Institute of Allergy and Infectious Diseases
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NIH National Institutes of Health
PIAMA-NHS The Prevention and Incidence of Asthma and Mite Allergy -Natural 
History Study
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